Justin Ichida lab advances toward clinical development for ALS
A potential treatment for amyotrophic lateral sclerosis (ALS) developed by USC Stem Cell scientist Justin Ichida, PhD, is poised to enter clinical development for patients, following a recent license agreement between the pharmaceutical giant … Read More »